Literature DB >> 11102651

A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.

A C Haynes1, B Jackson, H Chapman, M Tadayyon, A Johns, R A Porter, J R Arch.   

Abstract

A variety of evidence implicates the orexins, especially orexin-A, in the regulation of food intake, but it has not been established whether this effect is mediated by the orexin-1 or orexin-2 receptor. In the present study, a selective orexin-1 receptor antagonist, 1-(2-methylbenzoxazol-6-yl)-3-[1,5]naphthyridin-4-yl urea hydrochloride (SB-334867-A), was administered intraperitoneally to rats under various conditions, and food consumption was subsequently measured over 24 h. In male rats, a single dose of SB-334867-A (30 mg/kg, i.p.) given during the light phase reduced both orexin-A-induced food intake (7 nmol, i.c.v.) and feeding stimulated by an overnight fast for 4 h. When given at the start of the dark phase, food consumption was reduced in both male and female rats over 24 h. Daily injections at the start of the dark phase for 3 days reduced natural feeding in male rats over 24 h on days one and three. These findings demonstrate direct inhibition of orexin-A induced food intake with a selective orexin-1 receptor antagonist. Furthermore, the suppression of nocturnal feeding and food intake stimulated by an overnight fast supports other evidence that orexin-A is involved in the regulation of natural feeding and suggests that orexin-1 receptor antagonists could be useful in the treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102651     DOI: 10.1016/s0167-0115(00)00199-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  93 in total

1.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

2.  Evidence for the role of hindbrain orexin-1 receptors in the control of meal size.

Authors:  Eric M Parise; Nicole Lilly; Kristen Kay; Amanda M Dossat; Rohit Seth; J Michael Overton; Diana L Williams
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

Review 3.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

4.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

Review 5.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

6.  Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats.

Authors:  S G Nair; S A Golden; Y Shaham
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

7.  Orexin inputs to caudal raphé neurons involved in thermal, cardiovascular, and gastrointestinal regulation.

Authors:  Hans-Rudolf Berthoud; Laurel M Patterson; Gregory M Sutton; Christopher Morrison; Huiyuan Zheng
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

8.  Centrally administered orexin A increases motivation for sweet pellets in rats.

Authors:  A J Thorpe; J P Cleary; A S Levine; C M Kotz
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

9.  Sleep, brain energy levels, and food intake: Relationship between hypothalamic ATP concentrations, food intake, and body weight during sleep-wake and sleep deprivation in rats.

Authors:  M Dworak; T Kim; R W McCarley; R Basheer
Journal:  Somnologie (Berl)       Date:  2011-06

Review 10.  Therapeutics development for addiction: Orexin-1 receptor antagonists.

Authors:  David A Perrey; Yanan Zhang
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.